<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
	<generator>RSS Feed Creator Pro (Unlicensed)</generator>
	<pubDate>23 Aug 2010 11:18:36 GMT</pubDate>
	<title>WSNS News</title>
	<description>The latest neuroglogy news in Washington State.</description>
	<link>http://www.washingtonneurology.org/</link>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<atom:link href="http://www.washingtonneurology.org/rss.xml" rel="self" type="application/rss+xml" />
		
		
						<item>
	<title>Tysabri (natalizumab): New Risk Factor for PML</title>
	<description>ISSUE: FDA notified healthcare profesisonals that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML). PML is a rare but serious brain infection associated with use of Tysabri (natalizumab) for the treatment of multiple sclerosis (MS) or Crohn's disease.
 &lt;a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm288602.htm"&gt;More&lt;/a&gt;(01/24/12)</description>
	<pubDate>Mon, 23 Jan 2012 13:00:00 GMT</pubDate>
	<link>http://www.washingtonneurology.org/</link>
	<guid>http://www.washingtonneurology.org/</guid>
	
	</item>	
		

		


	</channel></rss>

